Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
The Journal of Antimicrobial Chemotherapy
|
January 1, 1993
The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone
R Wise, J M Andrews, N Brenwald
Antimicrobial Agents and Chemotherapy
|
May 1, 1996
In vitro activity of the tricyclic beta-lactam GV104326
R Wise, J M Andrews, N Brenwald
The Journal of Antimicrobial Chemotherapy
|
April 1, 1993
The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone
R Wise, J M Andrews, N Brenwald
Lancet (London, England)
|
December 14, 1996
Streptococcus pneumoniae resistance to fluoroquinolones
R Wise, N Brenwald, M Gill, et al.
Journal of Medical Microbiology
|
January 1, 1992
Resistance to desiccation and skin fatty acids in outbreak strains of methicillin-resistant Staphylococcus aureus
M Farrington, N Brenwald, D Haines, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1995
In-vitro activity of two glycylcyclines against enterococci resistant to other agents
A P Fraise, N Brenwald, J M Andrews, et al.
The Journal of Antimicrobial Chemotherapy
|
September 18, 2004
Susceptibility testing Pasteurella multocida by BSAC standardized methodology
J M Andrews, G Jevons, N Brenwald, et al.
The Journal of Antimicrobial Chemotherapy
|
November 1, 1993
The in-vitro activity of a new highly active quinolone, DU-6859a
A Jolley, J M Andrews, N Brenwald, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 1997
A reassessment of the in-vitro activity of colistin sulphomethate sodium
C R Catchpole, J M Andrews, N Brenwald, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1995
The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents
J Child, J Andrews, F Boswell, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
The Journal of Antimicrobial Chemotherapy
|
January 1, 1993
The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone
R Wise, J M Andrews, N Brenwald
Antimicrobial Agents and Chemotherapy
|
May 1, 1996
In vitro activity of the tricyclic beta-lactam GV104326
R Wise, J M Andrews, N Brenwald
The Journal of Antimicrobial Chemotherapy
|
April 1, 1993
The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone
R Wise, J M Andrews, N Brenwald
Lancet (London, England)
|
December 14, 1996
Streptococcus pneumoniae resistance to fluoroquinolones
R Wise, N Brenwald, M Gill, et al.
Journal of Medical Microbiology
|
January 1, 1992
Resistance to desiccation and skin fatty acids in outbreak strains of methicillin-resistant Staphylococcus aureus
M Farrington, N Brenwald, D Haines, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1995
In-vitro activity of two glycylcyclines against enterococci resistant to other agents
A P Fraise, N Brenwald, J M Andrews, et al.
The Journal of Antimicrobial Chemotherapy
|
September 18, 2004
Susceptibility testing Pasteurella multocida by BSAC standardized methodology
J M Andrews, G Jevons, N Brenwald, et al.
The Journal of Antimicrobial Chemotherapy
|
November 1, 1993
The in-vitro activity of a new highly active quinolone, DU-6859a
A Jolley, J M Andrews, N Brenwald, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 1997
A reassessment of the in-vitro activity of colistin sulphomethate sodium
C R Catchpole, J M Andrews, N Brenwald, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1995
The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents
J Child, J Andrews, F Boswell, et al.
Page
of 2